- Home
- GSK vs FCX Comparison
GSK vs FCX Comparison
Compare GSK & FCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSK
- FCX
- Stock Information
- Founded
- GSK 1715
- FCX 1987
- Country
- GSK United Kingdom
- FCX United States
- Employees
- GSK N/A
- FCX 27200
- Industry
- GSK Biotechnology: Pharmaceutical Preparations
- FCX Metal Mining
- Sector
- GSK Health Care
- FCX Basic Materials
- Exchange
- GSK Nasdaq
- FCX Nasdaq
- Market Cap
- GSK 68.2B
- FCX 57.9B
- IPO Year
- GSK N/A
- FCX N/A
- Fundamental
- Price
- GSK $33.78
- FCX $40.29
- Analyst Decision
- GSK Hold
- FCX Buy
- Analyst Count
- GSK 5
- FCX 11
- Target Price
- GSK $45.50
- FCX $53.36
- AVG Volume (30 Days)
- GSK 3.5M
- FCX 11.1M
- Earning Date
- GSK 02-05-2025
- FCX 01-23-2025
- Dividend Yield
- GSK 4.62%
- FCX 1.49%
- EPS Growth
- GSK N/A
- FCX N/A
- EPS
- GSK 0.81
- FCX 1.38
- Revenue
- GSK $41,966,224,352.00
- FCX $25,640,000,000.00
- Revenue This Year
- GSK $5.80
- FCX $14.69
- Revenue Next Year
- GSK $3.69
- FCX $5.43
- P/E Ratio
- GSK $20.19
- FCX $29.20
- Revenue Growth
- GSK 5.59
- FCX 12.91
- 52 Week Low
- GSK $31.72
- FCX $36.26
- 52 Week High
- GSK $45.93
- FCX $55.24
- Technical
- Relative Strength Index (RSI)
- GSK 50.09
- FCX 51.46
- Support Level
- GSK $31.72
- FCX $38.62
- Resistance Level
- GSK $34.46
- FCX $40.45
- Average True Range (ATR)
- GSK 0.47
- FCX 1.02
- MACD
- GSK 0.06
- FCX 0.39
- Stochastic Oscillator
- GSK 75.00
- FCX 82.67
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About FCX Freeport-McMoRan Inc.
Freeport-McMoRan owns stakes in 10 copper mines, led by its 49% ownership of the Grasberg copper and gold operations in Indonesia, 55% of the Cerro Verde mine in Peru, and 72% of Morenci in Arizona. It sold around 1.2 million metric tons of copper (its share) in 2023, making it the one of the world's largest copper miners by volume. It also sold about 900,000 ounces of gold, mostly from Grasberg, and 70 million pounds of molybdenum. About 75% of 2023 revenue was from copper, with a further 15% from gold and about 10% from molybdenum. It had about 25 years of copper reserves at end December 2023. we expect it to sell similar amounts of copper midcycle in 2028, though we expect gold volumes to decline to about 700,000 ounces then due to falling production at Grasberg.